|
시장보고서
상품코드
1350335
유전체학용 인공지능 시장 : 제공 형태별, 기능별, 용도별, 최종사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)Artificial Intelligence in Genomics Market, By Delivery Mode, By Functionality, By Application, By End User, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
유전체학용 인공지능(AI) 세계 시장 규모는 2023년 11억 5,000만 달러로 2023년부터 2030년까지 50.1%의 CAGR로 2030년에는 197억 2,000만 달러에 달할 것으로 예측됩니다.
| 보고 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준년도 | 2022 | 2023년 시장 규모 | 11억 5,000만 달러 |
| 과거 데이터 | 2018년부터 2021년까지 | 예측 기간 | 2023-2030 |
| 예측 기간 2023-2030년 CAGR: | 50.10% | 2030년 가치 예측 | 197억 2,000만 달러 |
인공지능(AI) 기술은 유전체 의학을 발전시킬 수 있는 큰 잠재력을 가지고 있으며, AI 기술의 기계학습과 기계학습의 일종인 딥러닝은 유전체 의학의 주요 분석 문제를 간소화할 수 있는 새로운 계산 접근법을 제공합니다.
시장 역학:
약물 및 진단의 처리 시간 단축에 대한 관심 증가, AI 기반 솔루션 채택 확대, 바이오메디컬 및 유전체 데이터 세트의 증가는 예측 기간 동안 전 세계 유전체학용 인공지능(AI) 시장의 성장을 확대할 것으로 예상되는 주요 요인입니다.
예를 들어, 2020년 11월, 바이오마린 파마슈티컬(BioMarin Pharmaceutical Inc.)과 딥지노믹스(Deep Genomics)는 딥지노믹스의 인공지능 신약개발 플랫폼(The AI Workbench)을 활용해 미충족 수요가 높은 4개 희귀질환 적응증에 대한 올리고뉴클레오티드 의약품 후보물질을 발굴하기 위한 전임상 공동연구를 시작한다고 발표했습니다.
본 조사의 주요 특징
- 이 보고서는 2022년을 기준 연도로 하여 예측 기간(2023-2030년)의 시장 규모와 CAGR을 제공하는 세계 유전체학용 인공지능(AI) 시장을 상세히 분석합니다.
- 또한 다양한 부문의 잠재적 수익 기회를 파악하고 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 주요 인사이트도 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등 다음과 같은 매개 변수를 기반으로 세계 유전체학용 인공지능(AI) 시장의 주요 기업들을 프로파일링했습니다.
- 이 조사의 일부로 다뤄지는 주요 기업은 Fabric Genomics, International Business Machines, Microsoft, NVIDIA, AI Therapeutics, Ares Genetics, Benevolent AI, Deep Genomics, Diploid 등이 있습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 유전체학용 인공지능(AI) 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 유전체학용 인공지능(AI) 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 가정
- 조사 목적
- 가정
- 약어
제2장 시장 개요
- 보고서 개요
- 시장 정의와 범위
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- Drug Discovery·진단의 납기 단축에 대한 주목 상승
- AI 기반 솔루션 채용 확대
- 바이오메디컬 및 게놈 데이터세트 증가
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- Porters 분석
- 인수합병 시나리오
제4장 유전체학용 인공지능 세계 시장 : 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19의 역학
- 공급측과 수요측 분석
- 경제적 영향
제5장 유전체학용 인공지능 세계 시장 : 제공 형태별, 2023-2030년
- 온프레미스
- 클라우드 기반
제6장 유전체학용 인공지능 세계 시장 : 기능별, 2023-2030년
- 게놈 시퀀싱
- 유전자 편집
- 기타
제7장 유전체학용 인공지능 세계 시장 : 용도별, 2023-2030년
- 중개 정밀의료
- 임상·게놈 진단
- 기타 용도
제8장 유전체학용 인공지능 세계 시장 : 최종사용자별, 2023-2030년
- 제약·바이오테크놀러지 기업
- 공공 및 소비자 게놈 센터
- 기타
제9장 유전체학용 인공지능 세계 시장 : 지역별, 2023-2030년
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제10장 경쟁 상황
- Fabric Genomics
- International Business Machines
- Microsoft
- NVIDIA
- AI Therapeutics
- Ares Genetics
- BENEVOLENTAI
- Deep Genomics
- Diploid
제11장 섹션
- 조사 방법
- 출판사 소개
The global artificial intelligence (AI) in genomics market was valued at US$ 1.15 Bn in 2023 and is forecast to reach a value of US$ 19.72 Bn by 2030 at a CAGR of 50.1% between 2023 and 2030.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 1.15 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 50.10% | 2030 Value Projection: | US$ 19.72 Bn |
Artificial intelligence (AI) techniques offer great potential for advancing genomic medicine. The AI techniques machine learning and deep learning, a type of machine learning offer new computational approaches to streamlining key analytical problems in genomic medicine
Market Dynamics:
Rising Focus on Reducing Turnaround Time in Drug Discovery & Diagnostics, Growing Adoption of Ai-Based Solutions, and Increased Biomedical and Genomic Datasets are major factors expected to augment growth of the global artificial intelligence (ai) in genomics market over the forecast period.
For instance, in November 2020, BioMarin Pharmaceutical Inc., and Deep Genomics announced that the companies have entered into a preclinical collaboration that will use Deep Genomics artificial intelligence drug discovery platform (The AI Workbench) to identify oligonucleotide drug candidates in four rare disease indications with high unmet need.
Key features of the study:
- This report provides in-depth analysis of the global artificial intelligence (ai) in genomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global artificial intelligence (ai) in genomics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Fabric Genomics, International Business Machines, Microsoft, NVIDIA, AI Therapeutics, Ares Genetics, Benevolent AI, Deep Genomics, Diploid, and among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global artificial intelligence (AI) in genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (ai) in genomics market.
Detailed Segmentation:
- Global Artificial Intelligence (AI) in Genomics Market, By Delivery Mode:
- On-Premises
- Cloud-Based
- Global Artificial Intelligence (AI) in Genomics Market, By Functionality:
- Genome Sequencing
- Gene Editing
- Others
- Global Artificial Intelligence (AI) in Genomics Market, By Application:
- Translational Precision Medicine
- Clinical & Genomic Diagnostics
- Others Applications
- Global Artificial Intelligence (AI) in Genomics Market, By End User:
- Pharma & Biotech Companies
- Public & Consumer Genomic Center
- Others
- Global Artificial Intelligence (AI) in Genomics Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles:
- Fabric Genomics
- International Business Machines
- MICROSOFT
- NVIDIA
- AI Therapeutics
- Ares Genetics
- Benevolent AI
- Deep Genomics
- Diploid
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Delivery Mode
- Market Snapshot, By Functionality
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising Focus on Reducing Turnaround Time in Drug Discovery & Diagnostics
- Growing Adoption of Ai-Based Solutions
- Increased Biomedical and Genomic Datasets
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Artificial Intelligence in Genomics Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Artificial Intelligence in Genomics Market, By Delivery Mode, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- On-Premises
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Cloud-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Artificial Intelligence in Genomics Market, By Functionality, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Genome Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Gene Editing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
7. Global Artificial Intelligence in Genomics Market, By Application, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Translational Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Clinical & Genomic Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
8. Global Artificial Intelligence in Genomics Market, By End User, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Pharma & Biotech Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Public & Consumer Genomic Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
9. Global Artificial Intelligence in Genomics Market, By Geography, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
10. Competitive Landscape
- Fabric Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- International Business Machines
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Microsoft
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NVIDIA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AI Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ares Genetics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BENEVOLENTAI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Deep Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Diploid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
비교리스트